CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 10,754	$ 2,545
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,620	5,546
Amortization of deferred finance charges	136	136
Deferred income taxes	3,636	0
Loss (gain) on disposition of assets	1	(96)
Fixed asset donations	(2,050)	(334)
Provision for doubtful accounts	19,816	21,692
Stock-based compensation expense	2,093	1,286
(Increase) decrease in assets:
Accounts receivable	(22,122)	(35,946)
Inventories	(761)	(1,258)
Prepaid income taxes and income taxes payable	(729)	272
Prepaid expenses and current assets	725	1,296
Other assets, net	274	(77)
Increase (decrease) in liabilities:
Accounts payable	(186)	1,656
Accrued expenses	(914)	4,663
CARES Act student funds liability	0	1,073
CARES Act institutional funds liability	0	10,387
Unearned tuition	1,238	(4,057)
Other liabilities	219	1,438
Total adjustments	6,996	7,677
Net cash provided by operating activities	17,750	10,222
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(5,252)	(3,554)
Proceeds from insurance	0	97
Net cash used in investing activities	(5,252)	(3,457)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on borrowings	(1,500)	(27,501)
Proceeds from borrowings	0	11,000
Dividend payment for preferred stock	(912)	(1,074)
Credit of deferred finance fees	0	3
Net share settlement for equity-based compensation	(962)	(244)
Net cash used in financing activities	(3,374)	(17,816)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	9,124	(11,051)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-Beginning of period	38,026	38,644
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-End of period	47,150	27,593
Cash paid for:
Interest	795	845
Income taxes	681	121
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Liabilities accrued for or noncash purchases of fixed assets	$ 2,684	$ 1,847